Log in
Enquire now
‌

US Patent 11364294 Vaccine compositions having improved stability and immunogenicity

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Novavax
Novavax
Current Assignee
Novavax
Novavax
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11364294
Date of Patent
June 21, 2022
Patent Application Number
15819962
Date Filed
November 21, 2017
Patent Citations
‌
US Patent 10729764 ISCOM preparation and use thereof
‌
US Patent 10022437 Modified RSV F proteins and methods of their use
‌
US Patent 10426829 Vaccine compositions having improved stability and immunogenicity
‌
US Patent 11253585 Vaccine compositions having improved stability and immunogenicity
Patent Primary Examiner
‌
Agnieszka Boesen

Disclosed herein are nanoparticles suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11364294 Vaccine compositions having improved stability and immunogenicity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.